Control of the SOST bone enhancer by PTH using MEF2 transcription factors
about
Prostaglandin E2 signals through PTGER2 to regulate sclerostin expressionEffects of PTH on osteocyte functionWNT signaling in bone homeostasis and disease: from human mutations to treatmentsLoad regulates bone formation and Sclerostin expression through a TGFβ-dependent mechanismMyocyte enhancer factor 2c, an osteoblast transcription factor identified by dimethyl sulfoxide (DMSO)-enhanced mineralizationParathyroid hormone signaling through low-density lipoprotein-related protein 6Single-pulsed electromagnetic field therapy increases osteogenic differentiation through Wnt signaling pathway and sclerostin downregulation.Nmp4/CIZ suppresses parathyroid hormone-induced increases in trabecular bone.Developments in sclerostin biology: regulation of gene expression, mechanisms of action, and physiological functions.Hypoxia decreases sclerostin expression and increases Wnt signaling in osteoblastsOsteoblast-specific expression of the fibrous dysplasia (FD)-causing mutation Gsα(R201C) produces a high bone mass phenotype but does not reproduce FD in the mouse.Sclerostin: current knowledge and future perspectives.Reduced renal calcium excretion in the absence of sclerostin expression: evidence for a novel calcium-regulating bone kidney axis.Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal womenGRM1 is upregulated through gene fusion and promoter swapping in chondromyxoid fibroma.OstemiR: a novel panel of microRNA biomarkers in osteoblastic and osteocytic differentiation from mesencymal stem cells.HDAC5 controls MEF2C-driven sclerostin expression in osteocytes.Mouse BMD quantitative trait loci show improved concordance with human genome-wide association loci when recalculated on a new, common mouse genetic mapParathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient miceGsα enhances commitment of mesenchymal progenitors to the osteoblast lineage but restrains osteoblast differentiation in mice.PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling.Acute decline in serum sclerostin in response to PTH infusion in healthy men.Hdac-mediated control of endochondral and intramembranous ossificationTGF-β regulates sclerostin expression via the ECR5 enhancer.A Comprehensive Overview of Skeletal Phenotypes Associated with Alterations in Wnt/β-catenin Signaling in Humans and Mice.DNA methylation regulates sclerostin (SOST) expression in osteoarthritic chondrocytes by bone morphogenetic protein 2 (BMP-2) induced changes in Smads binding affinity to the CpG region of SOST promoter.Genome-scale techniques highlight the epigenome and redefine fundamental principles of gene regulation.The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in Vitro.FoxA family members are crucial regulators of the hypertrophic chondrocyte differentiation program.Absence of sclerostin adversely affects B-cell survival.PTH and Vitamin D Repress DMP1 in Cementoblasts.Update on Wnt signaling in bone cell biology and bone disease.Lipoprotein receptor-related protein 6 is required for parathyroid hormone-induced Sost suppression.Targeted deletion of Sost distal enhancer increases bone formation and bone massRegulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostinSclerostin as a novel marker of bone turnover in athletes.The central nervous system (CNS)-independent anti-bone-resorptive activity of muscle contraction and the underlying molecular and cellular signatures.Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH.Short-term intermittent administration of parathyroid hormone facilitates osteogenesis by different mechanisms in cancellous and cortical boneSIKs control osteocyte responses to parathyroid hormone
P2860
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
P248
Q21560844-CDE7519D-96A5-4981-8CE5-FF17AFAD5DA2Q24631082-46D0A165-84CF-48C6-BB2B-19C2461DCCDDQ28285090-488FBEAD-11C6-48DF-9BE4-E6513B004CAEQ28484880-452FB143-CFC0-432F-9E75-B7D8EB49BF8FQ28507390-6BC52744-CA37-4F31-83A6-06C316023BB2Q28567926-4D32C5C1-5439-40EA-9506-2CA70B43ACC8Q30278695-C79394F0-9FF9-4EDF-A0E6-296946535E6CQ33405128-0DB7B884-F616-4C71-83B3-D4FF5D7A6408Q33564617-B6A33DB1-EA4D-4486-9D72-78505CFEA3E3Q33895465-49A6F5BB-1DB5-47BC-8A10-E013C3613336Q33926385-F1C40BC2-C87E-4766-BB53-F8CF4521F7DBQ33992612-3F5921CF-8A07-4CA9-9AED-A6BA7C202D42Q34260123-CA79B132-C721-4F4D-BA1C-60617853D5F9Q34262453-3E0334A9-3F99-4DA5-964A-FED38875BC77Q34411505-3080B3FB-7826-4073-9ADB-9BF29C0AD1D7Q34637681-C9A97AF8-3D33-4083-95E9-DBEDE3EC21E5Q35126180-6EFBE19E-88DC-44D6-9372-40D65CF7CA49Q35156123-D30F43D2-617F-4601-9573-9AD338822D3AQ35156214-B13E1060-2E85-4096-B76A-E06E1D7EED34Q35187105-09845896-C822-4FE7-ABC6-0A5FF2FF8A10Q35229920-8868BD8A-35FE-4CE4-9051-9AC252E2827DQ35498077-F4E34207-8B65-460D-A58F-4109758347B9Q35556841-FCE03762-A378-4C1C-B424-40CFFACE243EQ35754103-3C3926AC-4201-4904-BFE4-B6DD2B9A6BD7Q35755034-3EFC563F-B82B-41B2-A85B-B55EE5396883Q35816932-7F8AA242-3708-4B81-8866-3B335FDD56FCQ35853981-3BFB75F0-BA3A-4164-BA89-9903B100F6F8Q35860523-09E571BF-3549-465A-899F-9F1DCF781731Q35973892-66A00E58-84EB-4419-B912-77FA76C23251Q36040764-AEDD3412-BBCE-4E8D-AE19-BC64F5535424Q36081136-BF9065C8-2ECA-43C7-A59B-FAAA97D07DA6Q36083303-933C2379-CF0E-4EAB-AA9B-397DA6CB1678Q36117524-2A55EBC8-6DD6-40A1-B4A4-04E8F91B7299Q36212807-FCCFA0ED-5D67-4238-A9F0-0F04203CF55FQ36236285-857F0EEA-E136-4D74-AA39-7386933A062DQ36606834-AF4345AF-E0AE-45D2-9FD9-20840C2D46D9Q36832631-4701A96A-D283-4F99-A320-C01FA6EF6B23Q37012357-B9CAE68F-3BD3-4022-BEE7-BFB5EBB817FBQ37051678-F71E9D9B-38A8-4597-A3C5-CF1381A4EE12Q37360148-89A2C978-7238-403B-B4D8-8804FA4EBDB2
P2860
Control of the SOST bone enhancer by PTH using MEF2 transcription factors
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Control of the SOST bone enhancer by PTH using MEF2 transcription factors
@ast
Control of the SOST bone enhancer by PTH using MEF2 transcription factors
@en
Control of the SOST bone enhancer by PTH using MEF2 transcription factors
@en-gb
Control of the SOST bone enhancer by PTH using MEF2 transcription factors
@nl
type
label
Control of the SOST bone enhancer by PTH using MEF2 transcription factors
@ast
Control of the SOST bone enhancer by PTH using MEF2 transcription factors
@en
Control of the SOST bone enhancer by PTH using MEF2 transcription factors
@en-gb
Control of the SOST bone enhancer by PTH using MEF2 transcription factors
@nl
prefLabel
Control of the SOST bone enhancer by PTH using MEF2 transcription factors
@ast
Control of the SOST bone enhancer by PTH using MEF2 transcription factors
@en
Control of the SOST bone enhancer by PTH using MEF2 transcription factors
@en-gb
Control of the SOST bone enhancer by PTH using MEF2 transcription factors
@nl
P2093
P2860
P921
P3181
P356
P1476
Control of the SOST bone enhancer by PTH using MEF2 transcription factors
@en
P2093
François Natt
Hansjoerg Keller
Ina Kramer
Michaela Kneissel
Nicole M Collette
Olivier Leupin
P2860
P304
P3181
P356
10.1359/JBMR.070804
P407
P577
2007-12-01T00:00:00Z